Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer.
Saved in:
| Title: | Octreotide scintigraphy and Chromogranin A do not predict clinical response in patients with octreotide acetate-treated hormone-refractory prostate cancer. |
|---|---|
| Authors: | Kalkner, K. M.1 karl.kalkner@karolinska.se, Acosta, S.2, Thorsson, O.3, Frederiksen, H.4, Nilsson, A.5, Gustavsson, B.6, Elingsbo, M.6, Stridsberg, M.7, Abrahamsson, P-A.8 |
| Source: | Prostate Cancer & Prostatic Diseases. 2006, Vol. 9 Issue 1, p92-98. 7p. 4 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
